Search Results - "Lindstrom, Terry D."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Synthesis and biological evaluation of an orally active ghrelin agonist that stimulates food consumption and adiposity in rats by Lugar, Charles W., Clay, Michael P., Lindstrom, Terry D., Woodson, Andrea L., Smiley, David, Heiman, Mark L., Dodge, Jeffrey A.

    Published in Bioorganic & medicinal chemistry letters (06-12-2004)
    “…LY444711 is an orally active ghrelin agonist that binds with good affinity and is a potent activator of the growth hormone secretagogue receptor 1a (GHS-R1a)…”
    Get full text
    Journal Article
  6. 6

    In Vitro Biotransformation and Identification of Human Cytochrome P450 Isozyme-Dependent Metabolism of Tazofelone by SURAPANENI, S. S, CLAY, M. P, SPANGLE, L. A, PASCHAL, J. W, LINDSTROM, T. D

    Published in Drug metabolism and disposition (01-12-1997)
    “…Tazofelone is a new inflammatory bowel disease agent. The biotransformation of tazofelone in human livers and the cytochrome P450 responsible for the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury by Simpson, P J, Schelm, J A, Smallwood, J K, Clay, M P, Lindstrom, T D

    Published in Journal of cardiovascular pharmacology (01-06-1992)
    “…The purpose of this study was to determine whether the selective type IV cAMP-phosphodiesterase inhibitor rolipram could reduce the reperfusion injury that…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication by Stratford, Jr, R E, Clay, M P, Heinz, B A, Kuhfeld, M T, Osborne, S J, Phillips, D L, Sweetana, S A, Tebbe, M J, Vasudevan, V, Zornes, L L, Lindstrom, T D

    Published in Journal of pharmaceutical sciences (01-08-1999)
    “…Previous studies in rats and humans demonstrated poor oral bioavailability of potent in vitro 2-aminobenzimidazole inhibitors of rhinovirus replication due to…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes by Clay, Michael P., Hanssen, Brenda R., Surapaneni, Sekhar S., Lindstrom, Terry D.

    Published in Chirality (New York, N.Y.) (1999)
    “…Incubation of (R)‐tazofelone and (S)‐tazofelone in rat, dog, and human liver microsomes demonstrated that the (R)‐tazofelone enantiomer was more rapidly…”
    Get full text
    Journal Article
  13. 13

    Benzylamine antioxidants: relationship between structure, peroxyl radical scavenging, lipid peroxidation inhibition and cytoprotection by Yu, Melvin J, McCowan, Jefferson R, Phebus, Lee A, Towner, Richard D, Ho, Peter P. K, Keith, Priscilla T, Luttman, Charlotte A, Saunders, Royal D, Ruterbories, Kenneth J

    Published in Journal of medicinal chemistry (01-04-1993)
    “…Three homologous series of 3,5-dialkoxy-4-hydroxybenzylamines were prepared and tested (1) as peroxyl radical scavengers in homogeneous aqueous solution, (2)…”
    Get full text
    Journal Article
  14. 14

    Studies on cytochrome P-450-dependent lipid hydroperoxide reduction by Lindstrom, T D, Aust, S D

    Published in Archives of biochemistry and biophysics (01-01-1984)
    “…A reconstituted mixed-function oxidase system containing cytochrome P-450, cytochrome P-450 reductase, phosphatidylcholine, and NADPH catalyzed the reduction…”
    Get more information
    Journal Article
  15. 15

    Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats by Lindstrom, T D, Hanssen, B R, Bendele, A M

    Published in Molecular pharmacology (01-12-1990)
    “…Hepatic ischemia induced in vivo by ligation of the left hepatic lobe of rats for up to 2 hr had no effect on cytochrome P-450, cytochrome c reductase, or lobe…”
    Get more information
    Journal Article
  16. 16

    Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins by Brown, Raymond F, Kinnick, Michael D, Morin, John M, Vasileff, Robert T, Counter, Fred T, Davidson, Edward O, Ensminger, Paul W, Eudaly, Judith A, Kasher, Jeffrey S

    Published in Journal of medicinal chemistry (01-08-1990)
    “…The preparation and biological evaluation of a series of 7 beta-[2-(2-aminothiazol-4-yl)-2(Z)-methoximinoacetamido]cep halosporins, substituted at the…”
    Get full text
    Journal Article
  17. 17

    Inhibition of microsomal biotransformation by a series of nitrogen and oxygen heterocyclic histamine H2-antagonists by Lindstrom, T D, Whitaker, G W, Pioch, R P

    Published in Biochemical pharmacology (15-05-1987)
    “…A homologous series of potent, long-lasting thiazolo-pyrimidone-pyridine histamine H2-antagonists were examined for their inhibitory effects on rat hepatic…”
    Get more information
    Journal Article
  18. 18

    Discovery and development of a novel class of nonsteroidal aromatase inhibitors by Hirsch, K S, Jones, C D, Lindstrom, T D, Stamm, N B, Sutton, G P, Taylor, H M, Weaver, D E

    Published in Steroids (01-07-1987)
    “…Efforts to develop a novel class of nonsteroidal aromatase inhibitors began with the discovery that the infertility in male rats exposed to high levels of the…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Disposition of the aromatase inhibitor LY56110 and associated induction and inhibition studies in rats, dogs, and monkeys by Lindstrom, T D, Whitaker, G W

    Published in Fundamental and applied toxicology (01-05-1987)
    “…Compound LY56110 was well absorbed but slowly excreted in the rat, dog, and monkey. Oral administration of 5 mg/kg of [14C]LY56110…”
    Get more information
    Journal Article